TABLE 1.

Clinical characteristics of patients.

Patient	Gender	Tumor size(cm)	With LNM	With Hashimoto thyroiditis	BRAF V600E (mutation:+, wild type: –)	TSH (μIU/mL)a	T4 (nmol/L)b	T3 (nmol/L)c	FT (pmol/L)d	FT3 (pmol/L)e	TPOAB (IU/mL)f	TGAB (IU/mL)g
HT_PTC_1	Female	1.15 × 0.49	–	+	+	1.864	112.59	1.42	15.7	4.71	0.46	65.98
PTC_2	Female	1.4 × 1.0	+	–	+	0.553	98.25	1.2	16.78	3.56	0.81	2.08
PTC_3	Female	1.4 × 0.9	+	–	+	3.111	78.99	1.44	12.01	4.24	0.34	2.22
PTC_4	Male	0.7 × 0.4	–	–	–	2.077	88.42	1.68	12.96	4.83	<0.50	1.23
PTC_5	Female	1.1 × 0.8	+	–	+	1.581	81.5	1.53	12.73	4.4	<0.50	0.71
HT_PTC_6	Female	1.5 × 0.8	+	+	+	1.89	131.3	2.28	15.29	6.76	98.8	74.9
PTC_7	Male	1.4 × 1.0 × 0.8	+	–	+	0.794	102.7	1.71	12.22	5.41	<0.50	NA
HT_PTC_8	Female	1.8 × 1.1	+	+	–	0.763	100.6	1.46	12.46	4.49	100.57	490.71

Abbreviations: ^aThyroid-stimulating hormone. ^bThyroxine. ^cTriiodothyronine. ^dFree thyroxine. ^eFree triiodothyronine. ^fThyroid peroxidase antibody. ^gThyroglobulin antibody.